Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang
R
R
INSERM U76, C.N.T.S., Paris, France.
Bony
V
V
Lopez
M
M
D004999:Amifostine / Q000494:pharmacology; D000818:Animals; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D003114:Colony-Forming Units Assay; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000633:toxicity; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000473:pathology; D066298:In Vitro Techniques; D007939:Leukemia L1210 / Q000473:pathology / Q000628:therapy; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D014182:Transplantation, Autologous
C048341:mafosfamide; D003520:Cyclophosphamide; D004999:Amifostine